These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 14608364)

  • 21. Recombinant E. coli prototype strains for in vivo glycorandomization.
    Williams GJ; Yang J; Zhang C; Thorson JS
    ACS Chem Biol; 2011 Jan; 6(1):95-100. PubMed ID: 20886903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fermenting next generation glycosylated therapeutics.
    Chen X
    ACS Chem Biol; 2011 Jan; 6(1):14-7. PubMed ID: 21250649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversible sugar transfer by glycosyltransferases as a tool for natural product (bio)synthesis.
    Bode HB; Müller R
    Angew Chem Int Ed Engl; 2007; 46(13):2147-50. PubMed ID: 17300123
    [No Abstract]   [Full Text] [Related]  

  • 24. Substrate specificity of NovM: implications for novobiocin biosynthesis and glycorandomization.
    Albermann C; Soriano A; Jiang J; Vollmer H; Biggins JB; Barton WA; Lesniak J; Nikolov DB; Thorson JS
    Org Lett; 2003 Mar; 5(6):933-6. PubMed ID: 12633109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combinatorial synthesis of aminoglycoside libraries.
    Sucheck SJ; Shue YK
    Curr Opin Drug Discov Devel; 2001 Jul; 4(4):462-70. PubMed ID: 11727311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sugar-assisted ligation of N-linked glycopeptides with broad sequence tolerance at the ligation junction.
    Brik A; Ficht S; Yang YY; Bennett CS; Wong CH
    J Am Chem Soc; 2006 Nov; 128(46):15026-33. PubMed ID: 17105315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of high-affinity peptide ligands for vancomycin.
    Yao N; Wu CY; Xiao W; Lam KS
    Biopolymers; 2008; 90(3):421-32. PubMed ID: 18260149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Features and applications of bacterial glycosyltransferases: current state and prospects.
    Luzhetskyy A; Bechthold A
    Appl Microbiol Biotechnol; 2008 Oct; 80(6):945-52. PubMed ID: 18777021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural-product sugar biosynthesis and enzymatic glycodiversification.
    Thibodeaux CJ; Melançon CE; Liu HW
    Angew Chem Int Ed Engl; 2008; 47(51):9814-59. PubMed ID: 19058170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding substrate specificity of GT-B fold glycosyltransferase via domain swapping and high-throughput screening.
    Park SH; Park HY; Sohng JK; Lee HC; Liou K; Yoon YJ; Kim BG
    Biotechnol Bioeng; 2009 Mar; 102(4):988-94. PubMed ID: 18985617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colchicine glycorandomization influences cytotoxicity and mechanism of action.
    Ahmed A; Peters NR; Fitzgerald MK; Watson JA; Hoffmann FM; Thorson JS
    J Am Chem Soc; 2006 Nov; 128(44):14224-5. PubMed ID: 17076473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small-molecule screening: it takes a village..
    Gordon EJ
    ACS Chem Biol; 2007 Jan; 2(1):9-16. PubMed ID: 17243777
    [No Abstract]   [Full Text] [Related]  

  • 33. An efficient Mitsunobu protocol for the one-pot synthesis of S-glycosyl amino-acid building blocks and their use in combinatorial spot synthesis of glycopeptide libraries.
    Ziegler T; Schips C
    Nat Protoc; 2006; 1(4):1987-94. PubMed ID: 17487187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploiting the reversibility of natural product glycosyltransferase-catalyzed reactions.
    Zhang C; Griffith BR; Fu Q; Albermann C; Fu X; Lee IK; Li L; Thorson JS
    Science; 2006 Sep; 313(5791):1291-4. PubMed ID: 16946071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and antibiotic activity of a small molecules library of 1,2,3-triazole derivatives.
    Aufort M; Herscovici J; Bouhours P; Moreau N; Girard C
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1195-8. PubMed ID: 18086525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of the platform for reverse chemical genetics targeting novel protein-protein interactions.
    Koga H
    Mol Biosyst; 2006 Mar; 2(3-4):159-64. PubMed ID: 16880933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sweet antibiotics - the role of glycosidic residues in antibiotic and antitumor activity and their randomization.
    Kren V; Rezanka T
    FEMS Microbiol Rev; 2008 Aug; 32(5):858-89. PubMed ID: 18647177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent advances in the study of synthesis and activity of vancomycin derivatives].
    Chen YY; Liu G
    Yao Xue Xue Bao; 2007 May; 42(5):463-9. PubMed ID: 17703765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ligandomics--a tool for the development of targeted treatments].
    Porkka K; Laakkonen P
    Duodecim; 2002; 118(11):1185-92. PubMed ID: 12239852
    [No Abstract]   [Full Text] [Related]  

  • 40. Enzymatic glycosylation of vancomycin aglycon: completion of a total synthesis of vancomycin and N- and C-terminus substituent effects of the aglycon substrate.
    Nakayama A; Okano A; Feng Y; Collins JC; Collins KC; Walsh CT; Boger DL
    Org Lett; 2014 Jul; 16(13):3572-5. PubMed ID: 24954524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.